Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 396-400

  Tohme, Rania A ^a   Bulkow, Lisa ^b   Homan, Chriss E ^c   Negus, Susan ^c   McMahon, Brian J ^b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c Liver Disease and Hepatitis Program   (United States)

Author keywords

Hepatitis B; Incidence; Reactivation of infection; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC HEPATITIS; COHORT ANALYSIS; COLON CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STOMACH CANCER; UNITED STATES; VIRUS DETECTION; VIRUS REACTIVATION;

AASLD; AFP; ALANINE AMINOTRANSFERASE; ALPHA-FETOPROTEIN; ALT; AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASE; ANTI-HBC; ANTI-HBE; ANTI-HBS; ANTIBODY TO HEPATITIS B CORE; ANTIBODY TO HEPATITIS B SURFACE ANTIGEN; ANTIBODY TO HEPATITIS E ANTIGEN; ASPARTATE AMINOTRANSFERASE; AST; BMI; BODY MASS INDEX; CI; CONFIDENCE INTERVAL; DEOXYRIBONUCLEIC ACID; DNA; HAZARD RATIO; HBEAG; HBSAG; HBV; HCC; HEPATITIS B; HEPATITIS B E ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VIRUS; HEPATOCELLULAR CARCINOMA; HR; INCIDENCE; NATIONAL INSTITUTES OF HEALTH; NIH; PCR; POLYMERASE CHAIN REACTION; REACTIVATION OF INFECTION; RISK FACTORS; SD; STANDARD DEVIATION.;

ADOLESCENT; ADULT; AGED; ALASKA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION GROUPS; RISK FACTORS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 84884530410     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.012     Document Type: Article

References (24)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005, 34 Suppl. 1:S1-S3.
2. Wasley A., Kruszon-Moran D., Kuhnert W., Simard E., Finelli L., McQuillan G., et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J Infect Dis 2010, 202:192-201.
3. McMahon B.J., Schoenberg S., Bulkow L., Wainwright R.B., Fitzgerald M.A., Parkinson A.J., et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol 1993, 138:544-549.
4. Vong S., Bell B.P. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004, 39:476-483.
5. McMahon B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49:S45-S55.
6. Hoofnagle J.H. Reactivation of hepatitis B. Hepatology 2009, 49:S156-S165.
7. Gigi E., Lalla T., Orphanou E., Sinakos E., Vrettou E., Raptopoulou-Gigi M. Long term follow-up of a large cohort of inactive HBsAg (+)/HBeAg (-)/anti-HBe (+) carriers in Greece. J Gastrointestin Liver Dis 2007, 16:19-22.
8. Bortolotti F., Guildo M., Bartolacci S., Cadrobbi P., Crivellaro C., Noventa F., et al. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study. Hepatology 2006, 43:556-562.
9. Chu C.M., Liaw Y.F. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol 2009, 104:1693-1699.
10. Gaia S., Marzano A., Olivero A., Abate M., Rizzetto M., Smedile A. Inactive hepatitis B virus carriers: a favourable clinical condition. Eur J Gastroenterol Hepatol 2005, 17:1435-1436.
11. Lok A.S.F., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
12. McMahon B.J., Holck P., Bulkow L., Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001, 135:759-768.
13. Simonetti J., Bulkow L., McMahon B.J., Homan C., Snowball M., Negus S., et al. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus. Hepatology 2010, 51:1531-1537.
14. Centers for Disease Control and Prevention. [accessed 10.10.11]. http://www.cdc.gov/obesity/defining.html.
15. Chen R.W., Piiparinen H., Seppanen M., Koskela P., Sarna S., Lappalainen M. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol 2001, 65:250-256.
16. Livingston S.E., Simonetti J.P., McMahon B.J., Bulkow L.R., Hurlburt K.J., Homan C.E., et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis 2007, 195:5-11.
17. Martinot-Peignoux M., Boyer N., Colombat M., Akremi R., Pham B.N., Ollivier S., et al. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 2002, 36:543-546.
18. Cacciola I., Spatari G., Pollicino T., Costantino L., Zimbaro G., Brancatelli S., et al. Virological profiles in hepatitis B virus inactive carriers: monthly evaluation in 1-year follow-up study. Liver Int 2005, 25:555-563.
19. Zacharakis G.H., Koskinas J., Kotsiou S., Papoutselis M., Tzara F., Vafeiadis N., et al. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in north Greece (part of the Interreg I-II/EC-project). J Med Virol 2005, 77:173-179.
20. Villeneuve J.P., Desrochers M., Infante-Rivard C., Willems B., Raymond G., Bourcier M., et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994, 106:1000-1005.
21. Chu C.M., Liaw Y.F. Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. Gastroenterology 2007, 133:1458-1465.
22. Taylor B.C., Yuan J.M., Shamliyan T.A., Shaukat A., Kane R.L., Wilt T.J. Clinical outcomes in adults with chronic hepatitis B in association with patient and viral characteristics: a systematic review of evidence. Hepatology 2009, 49:S85-S95.
23. Yang H.I., Yeh S.H., Chen P.J., IIoeje U.H., Jen C.L., Su J., et al. Associations between hepatitis B virus genotype and mutants and the risk for hepatocellular carcinoma. J Natl Cancer Inst 2008, 100:1134-1143.
24. McMahon B.J., Alward W.L., Hall D.B., Heyward W.L., Bender T.R., Francis D.P., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985, 151:599-603.